Abstract
Introduction:
The Uphold® transvaginal mesh is a lightweight mesh with only two fixation points to the sacrospinous ligaments.
Aims and Objectives:
The aim of this study was to assess the outcomes of the Uphold vaginal support system for the management of grades 3 to 4 cystocele at 1 year postoperative follow-up.
Methods:
We conducted a retrospective descriptive noncomparative study in women undergoing Uphold vaginal mesh insertion for the management of anterior vaginal wall prolapse between July 6, 2017, to April 30, 2019, at our center. The demographic, preoperative finding, intraoperative details, and postoperative complications were analyzed. Postoperative symptoms and examination findings were analyzed up to 1 year of follow-up.
Results:
A total of 183 women underwent vaginal mesh insertion during this time period. Concomitant vaginal hysterectomy was performed in 92.9%, concomitant sacrospinous ligament fixation in 71%, and concomitant midurethral sling insertion in 47% of the patients. The mean duration of surgery was 115.5 minutes and the mean blood loss was 231 mL. One hundred twenty-three patients (67.2%) attended the 1 year postoperative follow-up. At the 1 year follow-up examination, three patients (2.4%) had grade 2 cystocele and three patients had vaginal mesh erosion. All three patients with vaginal mesh extrusion were asymptomatic.
Conclusion:
Our study shows a high cure rate (97.6%) for grades 3 and 4 cystocele with low rates of complications such as vaginal mesh extrusion (2.4%) and dyspareunia (4.1%) with the use of Uphold vaginal mesh at 1 year follow-up.
Get full access to this article
View all access options for this article.